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Su He Wang1,2*, Yongyi Fan1 and James R Baker Jr1,2*Abstract
Background: BID functions as a bridge molecule between death-receptor and mitochondrial related apoptotic
pathways to amplify apoptotic signaling. Our previous studies have demonstrated a substantial increase in BID
expression in primary normal thyroid epithelia cells treated with inflammatory cytokines, including the combination
of IFNγ and IL-1β or IFNγ and TNFα. The aim of this study was to determine whether an increase in BID expression
in thyroid can induce autoimmune thyroiditis.
Methods: A transgenic mouse line that expresses human BID in thyroid cells was established by fusing a mouse
thyroglobulin (Tg) promoter upstream of human BID (Tg-BID). We tested whether the increased expression of
pro-apoptotic BID in thyroid would induce autoimmune thyroiditis, both in the presence and absence of 0.3%
iodine water.
Results: Our data show that Tg-BID mice in a CBA/J (H-2 k) background do not spontaneously develop autoimmune
thyroiditis for over a year. However, upon ingestion of iodine in the drinking water, autoimmune thyroiditis does
develop in Tg-BID transgenic mice, as shown by a significant increase in anti-Tg antibody and mononuclear cell
infiltration in the thyroid glands in 30% of mice tested. Serum T4 levels, however, were similar between iodine-treated
Tg-BID transgenic mice and the wild type mice.
Conclusions: Our data demonstrate that increased thyroid expression of BID facilitates the development of
autoimmune thyroiditis induced by iodine uptake. However, the overexpression of BID itself is not sufficient to initiate
thyroiditis in CBA/J (H-2 k) mice.
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Autoimmune (Hashimoto’s) thyroiditis is characterized by
lymphocytic infiltration of the parenchyma, causing a
dense accumulation of lymphocytes, plasma cells, and
macrophages with germinal center formation and thyroid
enlargement. Although the pathogenesis of autoimmune
thyroiditis is not entirely clear, studies have demonstrated
that increasing the local production of inflammatory
cytokines in the thyroid microenvironment plays a critical
role in facilitating apoptosis in thyrocytes, leading to* Correspondence: shidasui@umich.edu; jbakerjr@umich.edu
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unless otherwise stated.autoimmune thyroiditis [1-3]. Among various inflam-
matory cytokines, IFN-γ, TNF-α and IL-1β appear to be
critical since the combination of two such cytokines can
significantly facilitate the development of experimental
autoimmune thyroiditis (EAT) in mice [1,3,4], a well-
recognized animal model of autoimmune thyroiditis.
BH3 interacting-domain death agonist (BID) is a pro-
apoptotic Bcl-2 family member that functions as a bridge
molecule between two classic apoptotic pathways to
augment apoptotic signaling. Our previous studies
showed that the expression of BID in primary normal
thyroid cells was significantly increased by inflammatory
cytokines in vitro [3]. The pretreatment of those inflam-
matory cytokines can also sensitize thyroid epithelia cells
to death-receptor mediated apoptosis [2,3]. This findingtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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autoimmune thyroiditis. A number of recent reports
have also indicated the involvement of BID in the devel-
opment of other autoimmune diseases [5-7]. We there-
fore hypothesized that the overexpression of BID plays a
positive role in the development of autoimmune thyroi-
ditis. To test this hypothesis we first established a trans-
genic mouse line that expresses human BID specifically
in the thyroid, and then tested whether the overexpres-
sion of BID alone is sufficient for the development of
autoimmune thyroiditis.
It has also been shown that there is connection bet-
ween iodine ingestion and autoimmune thyroiditis.
Indeed, iodine administration has been implicated in
increasing incidence and/or severity of spontaneous
thyroiditis in BB/W rats, CS chickens, hamsters and
NOD-H-2 h4 mice [8]. CBA/J (H-2 k) mice, however,
are genetically susceptible to EAT induced by Tg but are
resistant to EAT induced by iodine intake alone [8-10].
In this study, we employed CBA/J (H-2 k) mice to exa-
mine whether the overexpression of BID can overcome
this resistance, and sensitize these mice to iodine-
induced autoimmune thyroiditis.Figure 1 Expression of Tg-BID plasmid in the TNT T7 Quick
Coupled transcription/translation system. 1 μg of CMV-BID, Tg-BID,
Tg, and pCDNA3.1 were added to TNT T7 quick reaction. A 2.5-μl aliquot
of each reaction was separated on a 15% SDS-PAGE gel and BID protein
was recognized by a specific anti-BID antibody.Methods
Tg-BID transgenic mice
To produce a transgenic mouse line that overexpresses
human BID specifically in the thyroid, a rat thyroglobu-
lin (Tg) promoter was fused with the human BID gene.
To accomplish this, the rat Tg promoter region was
amplified by PCR using rat genomic DNA as a template
and primers with internal Afl II/KpnI sites (Forward pri-
mer 5′ata tac tta ctt aag ctg cag aca agc agg cat gc-3′;
Reverse primer 5′tta act ata ggt acc tac tca aat gat ggg
gta gga g-3′). After digestion, the fragment was fused
upstream of 0.9 kb of BID cDNA sequence (accession
no.AF042083). Then, Tg-BID transgene was cloned into
pCMV or pcDNA3.1 (Invitrogen). After confirming the
correct sequence for the Tg promoter and insertion site,
a 2515 bp Tg-BID transgene fragment released by Bg1II/
NaeI was used to develop transgenic mice in the Trans-
genic Core of our institute. The Tg-BID transgene was
microinjected into eggs from C57BL/6 J x CBA/J (H-2 k)
female mice. The Tg-BID positive C57BL/6 J x CBA/J
(H-2 k) mice were confirmed by PCR. CBA/J (H-2 k)
mice, which have a genetic predisposition to develop
EAT [8,9], were crossed with the Tg-BID positive
C57BL/6 J x CBA/J (H-2 k) mice to produce C1 mice.
Subsequent generations (C2-C8) were produced with
similar backcrosses. All animal experiments were con-
ducted following a protocol approved by the University
of Michigan Committee on the Use and Care of Animals
(UCUCA) (Approval Ref No. PRO00005076).RNA isolation and RT-PCR
RNA was extracted from mouse thyroid tissues by Trizol
(Invitrogen) and converted to cDNA by reverse transcrip-
tion, using M-MLV Reverse Transcriptase. The cDNA was
then amplified by real time PCR, using the Mastercycler® ep
real plex (Eppendorf). The forward and backward primers
for BID were 5′-AAGAAGGTGGCCAGTCACAC-3′ and
5′-GTCCATCCCATTTCTGGCTA-3′, respectively. The
β-actin (5′-ACTGCTCTGGCTCCTAGCAC-3′ and 5′-AC
ATCTGCTGGAAGGTGGAC-3) was also measured by
RT-PCR from the same RNA samples and was used as an
internal control. mRNA expression was quantified using
the comparative CT (cross threshold, the PCR cycle num-
ber that crosses the signal threshold) method as previously
described [4].Protein isolation and detection
Mouse tissue protein was isolated from Trizol homoge-
nized tissues after extraction of RNA, according to the
manufacturer’s protocol (Invitrogen). Western blots were
performed according to the previous procedures [1-4].
BID expression was also detected by immunohistochemis-
try. Briefly, mouse primary thyroid cells cultured in 8-well
plates were stained with mouse anti-human BID antibody
(IgG1, BD Transduction Laboratories), then stained with
goat anti-mouse IgG1-Cy2 and DAPI.Induction and evaluation of autoimmune thyroiditis
8-week old, female BID transgenic mice and age matched
wild type mice were given iodine water (0.3% of Sodium
iodide) for 8 weeks. Evaluation of thyroiditis was done by
measuring serum anti-Tg antibody and examining thyroid
histopathology in BID transgenic mice and wild type mice.
10 mice were included for each group. Serum anti-Tg anti-
body was determined by solid-phase ELISA as previous
described [11]. Briefly, plastic microtiter plates were
coated with 100 μl of murine Tg (10 μg/ml), and sera from
individual mice in 1:50, 1:100, and 1:200 dilutions were
added to each well. An alkaline phosphatase-conjugated,
sheep anti-mouse IgG (Sigma) was added to determine
anti-Tg IgG. Thyroid histopathology was examined as de-
scribed in our previous publications [1,4].
Figure 2 Transgene BID protein expressed in FRTL-5 cells and FRTL-5 cells treated with TSH. Total protein was isolated from FRTL-5 cells
transfected with pcDNA3.1-Tg-BID and subjected to Western blot for the transgene Bid protein (A). Total protein from FRTL-5 cells transfected
with pcDNA3.1-TgBID and treated with a series of diluted TSH for 72 hours was also isolated and subjected to Western blot to detect BID
(B). GAPDH was used as a loading control.
Table 1 Quantification of Tg-BID mRNA expression in
mouse thyroid by RT-PCR
Mice Subgroup n Tg-BID level
Wild type 8 0
Transgenic Low 8 5
Transgenic Medium 8 37
Transgenic High 8 118
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The values given are presented as mean ± SD. Statistical
analysis was performed using one-way analysis of va-
riance (ANOVA) followed by Student’s t test. p < 0.05
was considered as significant.
Results
Establishment of transgenic mice with BID overexpression
in thyroid gland
To generate Tg-BID transgenic mice, the rat Tg promoter
region was fused upstream of the Bid transgene and
cloned into pCMV to form CMV-BID. Sequence analysis
was used to confirm that the Tg-BID plasmid had the
correct sequence for the Tg promoter and insertion site.
To verify expression of BID from the Tg-BID construct,
the TNT-coupled transcription/translation system was
used according to the manufacturer’s protocol. Under
in vitro transcription/translation conditions, the Tg-BID
construct expressed a BID protein of the predicted size
(23 kD), which was the same size produced by the CMV-
BID (Figure 1). It is obvious that CMV promoter is much
stronger than the Tg promoter. This verified that the BID
protein translated from these transgenes can be recog-
nized by anti-BID antibody.
The expression of the transgene has also been validated
in transfected FRTL-5 cells. The pcDNA3.1-Tg-BID trans-
gene was efficiently expressed in FRTL-5 cells transfected
with pcDNA3.1-Tg-BID, but not in FRTL-5 cells trans-
fected with control pcDNA3.1-Tg plasmid (Figure 2A). In
a second set of experiments, FRTL-5 cells transfected with
pcDNA3.1-Tg-BID were cultured in complete media with-
out TSH for one week, followed by the addition of
0–0.625 mU/ml of TSH for 72 hours. It is known that
TSH is able to activate Tg promoter. Figure 2B shows that
BID protein expression was regulated by TSH, confirming
the functionality of the Tg promoter.Assessment of spontaneous thyroiditis in Tg-BID CBA/J
(H-2 k) mice
Tg-BID positive C57BL/6 J X CBA/J (H-2 k) mice were
crossed with CBA/J (H-2 k) mice, which are a strain
genetically susceptible to EAT [8-10], to produce C1
mice, and subsequent generations were made with simi-
lar backcrosses. RNAs extracted from the C4 transgenic
mice thyroids demonstrated message for Tg-BID positive
mice, but not in DNA negative mice (Table 1), nor in
other tissues in the transgene positive mice (data not
shown). The expression of BID protein was examined in
the thyroid from the founder to C4 transgenic mice
using Western blot and found that a considerable num-
ber of mice expressed BID (Figure 3). Mice with high,
medium and low levels of Tg-BID were defined based on
the relative level of Tg-BID protein as compared to the
actin control. Clones with very high levels of Tg-BID
relative to actin controls were considered “high” (e.g.,
clones 55 and 205 in Figure 3); clones with Tg-BID levels
that were similar to the actin control were considered
“medium” (e.g., clones 534 and 102); and clones with
very low levels of Tg-BID relative to the control were
considered “low” (e.g., clones 66 and 118). Clones
positive for BID by Western blot were confirmed by
immunofluorescent staining of cultured primary mouse
thyrocytes (Figure 4). It was noted that the levels of BID
protein in the positive clones were various, which
Figure 3 Expression of transgene Tg-BID in the thyroid of the founder (A), C1 (B) and C2 (C) mice. Mouse thyroid cells were isolated and
cell lysates prepared and subjected to Western blot for BID. Actin was detected as a control for equal loading. The number represents different
clones of transgenic mice. WT: wild type.
Wang et al. Journal of Translational Medicine 2014, 12:180 Page 4 of 7
http://www.translational-medicine.com/content/12/1/180enabled us to divide the transgenic mice into high,
medium and low Tg-BID expression group for the fur-
ther function study.
Though the levels of Tg-BID proteins were highly vari-
able in those transgenic mice, no anti-Tg antibody was
detectable in sera. In addition, serum T4 levels were not
different between Tg-BID transgenic mice and wild-type
mice. Furthermore, the gross appearance and micro-
structure of thyroid glands in all transgenic mice ap-
peared similar to that of the wild-type mice, suggesting
that the overexpression of BID itself has no impact on
thyroid function in terms of T4, and does not cause a
notable autoimmune response in the thyroid gland.Figure 4 Immunofluorescent staining of cultured primary mouse thyr
panel: DAPI nuclear staining of wild type (WT) and transgene positive cells.
Right panel: Merged DAPI and CY3-BID staining of WT and transgene positIodine induced autoimmune thyroiditis in Tg-BID
transgenic CBA/J (H-2 k) mice
As demonstrated above, no spontaneous thyroiditis was
observed in Tg-BID transgenic CBA/J (H-2 k) mice. To in-
vestigate whether BID can cooperate with other thyroiditis
risk factors to facilitate the development of autoimmune
thyroiditis, we treated mice with iodine, a known risk fac-
tor for thyroiditis [10,12,13]. Mice treated with 0.3% iodine
begin to show an increase in anti-Tg antibody at Week 4 in
Tg-BID transgenic mice compared with wild type CBA/J
(H-2 k) mice, and the level of anti-Tg antibody was signifi-
cantly higher at Week 8 (* p < 0.01, Figure 5). Consistent
with this increase in anti-Tg antibody, 3 of 10 Tg-BIDocytes from wild type and Tg-BID postive transgenic mice. Left
Middle panel: CY3-BID staining of WT and transgene positive cells.
ive cells.
Figure 5 Elevation of serum thyroid autoantibody anti-Tg in
Tg-BID transgenic CBA/J mice treated with iodine. Sera were
collected from the mice before iodine administration (pre-treatment),
4 weeks after iodine administration and 8 weeks after iodine
administration. Anti-Tg antibody was measured by solid-phase ELISA
and results were expressed as OD 405 ± SD of 1:200 dilution of serum
from ten individual mice per group.
Figure 6 Thyroid histology. Representative hematoxylin and eosin
staining of thyroid glands of the wild type CBA/J (H-2 k) mice
(A) and Tg-BID transgenic CBA/J (H-2 k) (B). Obvious inflammatory
infiltration was observed in the latter but not in the former.
Magnification =20X.
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mononuclear cell infiltration whereas no thyroids of the
wild type CBA/J (H-2 k) had this phenotype (Figure 6).
Despite the increase of serum anti-Tg antibody and mono-
nuclear cell infiltration, serum T4 levels were similar bet-
ween iodine-treated Tg-BID transgenic CBA/J (H-2 k) mice
and wild-type CBA/J (H-2 k) mice. These findings suggest
that the thyroid function of the Tg-BID transgenic mice ap-
pears within the normal range after receiving 8-week iodine
in the drinking water, even though iodine uptake does re-
sult in a certain degree of autoimmune responses such as
autoantibody production and mononuclear cell infiltration
in Tg-BID transgenic mice.
Discussion
Our previous work demonstrated that the Fas pathway
in thyrocytes can be activated by Fas ligand in the pres-
ence of combinations of pro-inflammatory cytokines
such as IL-1β, IFNγ and TNFα [1,2]. Further experi-
ments revealed that the induction of apoptosis in thyro-
cytes is correlated with an increase of BID and Bak
levels but a decrease of p44/42 mitogen-activated pro-
tein kinase activity [2,14,15]. These findings suggest that
the Fas apoptotic pathway activity may be further ampli-
fied by the bridge pro-apoptotic molecule BID, leading
to the release of Bak from the mitochondria and activa-
tion of caspases. Thus, apoptosis of thyrocytes in EAT
or autoimmune thyroiditis is dependent on both cell
death receptors and mitochondrial elements, in which
BID plays a critical role [16,17]. In contrast to mostapoptotic activity, apoptotic cell death in EAT or auto-
immune thyroiditis is not anti-inflammatory [18]. In-
stead, apoptotic thyroid cells and secondary necrotic
cells induce a pro-inflammatory environment, which
may provide sufficient levels of self-antigens to intensify
a deregulated immune response [18,19]. The occurrence
of inflammation is now known to be closely associated
with a BID-related pathway that is either dependent or
independent of apoptosis [20-22].
To test whether the genetic changes in BID play a role
in the development of autoimmune thyroiditis, we suc-
cessfully developed a transgenic mouse line in which
BID is specifically over-expressed in the thyroid. We ob-
served Tg-BID transgenic mice for 15 months, and du-
ring this period these mice remained healthy. These
mice showed no obvious difference in activity and ap-
pearance compared with the control mice. In addition,
no difference in thyroid histology and morphology were
observed. We found that regardless of the level of BID
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were observed in the growth of mice, their activity, or
serum T4 levels. Importantly, the classical features of
thyroiditis, such as thyroid auto-antibodies, did not
appear in any of the transgenic Tg-BID mice. These find-
ings indicate that the overexpression of BID alone is not
sufficient to cause the pathologic phenotype characte-
ristic of spontaneous thyroiditis in mice.
The observation that Tg-BID transgenic mice do not
develop spontaneous autoimmune thyroiditis is not to-
tally unexpected. Autoimmune thyroiditis is a disorder
with multiple causative factors including genetic, envi-
ronmental, and immunological elements [18,23]. Among
these elements, iodine is able to exert pleiotropic effects
on either metabolic or immunological processes of thy-
roid. While iodine is an indispensable constituent of the
two major thyroid hormones T3 and T4 [24], it contri-
butes to the development of autoimmune thyroiditis by
enhancing the antigenicity of thyroglobulin and reducing
regulatory T cells [13,25]. Though iodine is known to
contribute to the development of autoimmune thyroi-
ditis [8-10], it may not be able to do so without other
co-factors. For example, iodine is able to induce thyroid-
itis in nearly 100% of NOD.H-2 h4 mice that express
I-Ak on the NOD genetic background, but cause none
in mice such as CBA/J (H-2 k) (H-2 k) and NOD.SWR
(H-2(q)) that do not carry I-Ak [8]. It is unknown
whether mice with BID overexpression would sensitize
thyroiditis induced by iodine. To this end, we employed
iodine-resistant CBA/J (H-2 k) mice in this study. We
show that upon iodine administration, Tg-BID trans-
genic CBA/J (H-2 k) mice do indeed develop auto-
immune thyroiditis in about 8 weeks, which is evident
by a significant increase in serum anti-Tg autoantibody
and 30% of Tg-BID transgenic CBA/J (H-2 k) mice hav-
ing mononuclear cell infiltration into the thyroid glands.
The timing of iodine-induced autoimmune thyroiditis in
Tg-BID transgenic CBA/J (H-2 k) mice appears to be
quite similar to that in NOD-H-2 h4 mice [8].Conclusions
Our study has demonstrated that the increasing BID ex-
pression specifically in thyroid does not cause autoimmune
thyroiditis. However, mice with thyroid-specific BID over-
expression are at high risk of development of autoimmune
thyroiditis induced by known pathogenic factors such as
iodine. These findings support the common concept that
autoimmune thyroiditis is a multi-factorial disease, result-
ing from interplay of genetic, environmental, and en-
dogenous factors [18,23].
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